Q32 Bio Inc. — Director's Dealing 2021

Apr 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2021-04-07

Reporting Person: Kelly Timothy P (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-07	Employee Stock Option (Right to Buy)	$7.18	A	10000	Acquired	2031-04-07	Common Stock (10000)	Direct

Footnotes

F1: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after April 12, 2021, so that such option will become fully vested on April 12, 2025.